1. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma. (7th February 2015) Authors: Flørenes, Vivi Ann; Emilsen, Elisabeth; Dong, Hiep Phuc; Førsund, Mette; Holm, Ruth; Slipicevic, Ana Journal: Cancer medicine Issue: Volume 4:Number 6(2015:Jun.) Page Start: 903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro. (2nd July 2018) Authors: Wang, Zhihui; Førsund, Mette S.; Trope, Claes G.; Nesland, Jahn M.; Holm, Ruth; Slipicevic, Ana Journal: Cancer medicine Issue: Volume 7:Number 8(2018:Aug.) Page Start: 3955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines. (27th July 2020) Authors: Schepsky, Alexander; Traustadottir, Gunnhildur Asta; Joelsson, Jon Petur; Ingthorsson, Sævar; Kricker, Jennifer; Bergthorsson, Jon Thor; Asbjarnarson, Arni; Gudjonsson, Thorkell; Nupponen, Nina; Slipicevic, Ana; Lehmann, Fredrik; Gudjonsson, Thorarinn Journal: Cancer medicine Issue: Volume 9:Number 18(2020) Page Start: 6726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MX 2 is a novel regulator of cell cycle in melanoma cells. (13th November 2019) Authors: Juraleviciute, Marina; Pozniak, Joanna; Nsengimana, Jérémie; Harland, Mark; Randerson‐Moor, Juliette; Wernhoff, Patrik; Bassarova, Assia; Øy, Geir Frode; Trøen, Gunhild; Flørenes, Vivi Ann; Bishop, David Timothy; Herlyn, Meenhard; Newton‐Bishop, Julia; Slipicevic, Ana Journal: Pigment cell & melanoma research Issue: Volume 33:Number 3(2020) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy. (18th March 2021) Authors: Juraleviciute, Marina; Nsengimana, Jérémie; Newton‐Bishop, Julia; Hendriks, Gert J.; Slipicevic, Ana Journal: Cancer medicine Issue: Volume 10:Number 8(2021) Page Start: 2840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells. Issue 7 (12th July 2021) Authors: Byrgazov, Konstantin; Besse, Andrej; Kraus, Marianne; Slipicevic, Ana; Lehmann, Fredrik; Driessen, Christoph; Besse, Lenka Journal: HemaSphere Issue: Volume 5:Issue 7(2021) Page Start: e602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide. (July 2020) Authors: Byrgazov, Konstantin; Anderson, Claes; Salzer, Benjamin; Bozsaky, Eva; Larsson, Rolf; Gullbo, Joachim; Lehner, Manfred; Lehmann, Fredrik; Slipicevic, Ana; Kager, Leo; Fryknäs, Mårten; Taschner-Mandl, Sabine Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death. Issue 3 (25th March 2022) Authors: Flanagan, Ken; Kumari, Romika; Miettinen, Juho J.; Haney, Staci L.; Varney, Michelle L.; Williams, Jacob T.; Majumder, Muntasir M.; Suvela, Minna; Slipicevic, Ana; Lehmann, Fredrik; Nupponen, Nina N.; Holstein, Sarah A.; Heckman, Caroline A. Journal: HemaSphere Issue: Volume 6:Issue 3(2022) Page Start: e687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs. (February 2021) Authors: Byrgazov, Konstantin; Kraus, Marianne; Besse, Andrej; Slipicevic, Ana; Lehmann, Fredrik; Driessen, Christoph; Besse, Lenka Journal: Leukemia research Issue: Volume 101(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Wnt5A promotes an adaptive, senescent‐like stress response, while continuing to drive invasion in melanoma cells. (29th December 2014) Authors: Webster, Marie R.; Xu, Mai; Kinzler, Kathryn A.; Kaur, Amanpreet; Appleton, Jessica; O'Connell, Michael P.; Marchbank, Katie; Valiga, Alexander; Dang, Vanessa M.; Perego, Michela; Zhang, Gao; Slipicevic, Ana; Keeney, Frederick; Lehrmann, Elin; Wood, William; Becker, Kevin G.; Kossenkov, Andrew V.... Journal: Pigment cell & melanoma research Issue: Volume 28:Number 2(2015:Mar.) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗